| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MNDY | <0.01% | $15.42B | +28.15% | 0.00% |
| LEU | -<0.01% | $2.87B | +301.79% | 0.00% |
| EE | -0.02% | $911.59M | +53.92% | 0.72% |
| VSTA | 0.04% | $341.66M | +42.00% | 0.00% |
| KR | 0.05% | $47.17B | +41.48% | 1.81% |
| PBPB | -0.21% | $376.25M | +58.25% | 0.00% |
| IFRX | 0.27% | $53.71M | -53.76% | 0.00% |
| CNR | 0.34% | $3.44B | -36.77% | 1.02% |
| LITB | -0.36% | $22.07M | -77.41% | 0.00% |
| FC | 0.36% | $313.13M | -36.95% | 0.00% |
| JBI | 0.38% | $1.23B | -29.53% | 0.00% |
| PPC | -0.41% | $10.79B | +32.45% | 0.00% |
| BTU | 0.41% | $1.60B | -43.87% | 2.15% |
| STNG | 0.44% | $2.04B | -50.55% | 3.97% |
| RLX | 0.57% | $2.05B | +23.63% | 0.43% |
| PULM | 0.59% | $24.14M | +230.50% | 0.00% |
| AXON | -0.66% | $60.36B | +164.47% | 0.00% |
| TDUP | -0.72% | $921.14M | +389.94% | 0.00% |
| SMWB | -0.75% | $705.71M | +15.45% | 0.00% |
| FSLY | 0.84% | $1.01B | -2.65% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AZN | 48.72% | $221.62B | -7.18% | 2.19% |
| BIIB | 45.38% | $19.06B | -43.16% | 0.00% |
| GSK | 45.21% | $78.84B | +1.94% | 4.17% |
| ALC | 42.50% | $44.03B | +0.26% | 0.38% |
| SNY | 42.33% | $119.51B | +1.05% | 4.49% |
| NVS | 41.57% | $233.59B | +15.65% | 3.24% |
| ING | 40.39% | $67.10B | +26.27% | 5.34% |
| GILD | 39.89% | $138.98B | +63.35% | 2.80% |
| A | 39.77% | $34.22B | -4.24% | 1.01% |
| BRKR | 39.71% | $6.35B | -32.02% | 0.48% |
| QGEN | 39.44% | $10.44B | +15.16% | 0.00% |
| ARGX | 39.38% | $33.12B | +24.57% | 0.00% |
| TAK | 39.28% | $48.37B | +17.96% | 4.32% |
| ARVN | 38.78% | $556.92M | -69.30% | 0.00% |
| TECH | 37.95% | $8.16B | -26.90% | 0.62% |
| AMGN | 37.67% | $156.21B | -6.52% | 3.18% |
| ATR | 37.65% | $10.50B | +13.26% | 1.13% |
| DHR | 37.51% | $143.92B | -16.35% | 0.59% |
| BMRN | 37.17% | $10.78B | -31.66% | 0.00% |
| LIN | 37.15% | $224.42B | +10.85% | 1.21% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| K | -13.97% | $27.71B | +40.85% | 2.85% |
| BTCT | -8.45% | $22.63M | +43.33% | 0.00% |
| PAY | -7.77% | $4.03B | +65.72% | 0.00% |
| PTGX | -7.70% | $3.11B | +45.16% | 0.00% |
| HUSA | -7.39% | $21.26M | -8.69% | 0.00% |
| AIFU | -7.37% | $6.51B | +93.75% | 0.00% |
| XGN | -5.14% | $152.81M | +292.70% | 0.00% |
| TGI | -4.83% | $2.00B | +64.33% | 0.00% |
| STG | -4.49% | $30.47M | -21.87% | 0.00% |
| DSP | -4.25% | $832.76M | +27.61% | 0.00% |
| PRA | -3.84% | $1.17B | +87.59% | 0.00% |
| VERX | -3.45% | $5.61B | -0.73% | 0.00% |
| VSA | -3.25% | $8.76M | -18.25% | 0.00% |
| DAVE | -3.24% | $3.48B | +769.19% | 0.00% |
| FATBB | -3.08% | $46.69M | -10.89% | 10.69% |
| GALT | -2.96% | $140.51M | -2.63% | 0.00% |
| CALM | -2.58% | $5.43B | +64.80% | 6.59% |
| CPSH | -2.28% | $39.66M | +61.54% | 0.00% |
| ALHC | -2.25% | $2.81B | +80.33% | 0.00% |
| BBD | -2.05% | $16.10B | +49.88% | 1.31% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PZA | 0.01% | $2.84B | 0.28% |
| MMIN | 0.25% | $335.49M | 0.3% |
| WEAT | 0.29% | $117.67M | 0.28% |
| JMST | -0.37% | $4.06B | 0.18% |
| BILS | -0.45% | $3.83B | 0.1356% |
| GSST | 0.46% | $919.83M | 0.16% |
| SCHO | 0.46% | $11.46B | 0.03% |
| NYF | 0.46% | $890.74M | 0.25% |
| VGSH | -0.56% | $22.77B | 0.03% |
| BSMW | 0.61% | $107.29M | 0.18% |
| COMT | -0.65% | $607.04M | 0.48% |
| IEI | 0.66% | $15.41B | 0.15% |
| GSG | 0.67% | $963.89M | 0.75% |
| FMHI | -0.69% | $753.22M | 0.7% |
| DFNM | -0.69% | $1.57B | 0.17% |
| TIPX | 0.72% | $1.67B | 0.15% |
| IBTI | -0.73% | $1.06B | 0.07% |
| FMF | -0.78% | $157.12M | 0.95% |
| IBTJ | 0.90% | $684.86M | 0.07% |
| MMIT | 0.92% | $1.03B | 0.3% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IXJ | 54.82% | $3.73B | 0.41% |
| PPH | 53.21% | $612.06M | 0.36% |
| BBH | 52.90% | $329.37M | 0.35% |
| IBB | 52.20% | $5.28B | 0.45% |
| FBT | 50.98% | $1.01B | 0.54% |
| QEFA | 50.84% | $886.32M | 0.3% |
| EWL | 50.28% | $1.32B | 0.5% |
| BBEU | 50.14% | $4.56B | 0.09% |
| VIGI | 49.88% | $8.40B | 0.1% |
| IEV | 49.82% | $2.28B | 0.61% |
| IEUR | 49.82% | $6.83B | 0.09% |
| FHLC | 49.40% | $2.43B | 0.084% |
| IDLV | 49.35% | $399.03M | 0.25% |
| VHT | 49.28% | $15.27B | 0.09% |
| VGK | 49.27% | $26.02B | 0.06% |
| IDHQ | 49.07% | $463.03M | 0.29% |
| SPEU | 48.87% | $691.63M | 0.07% |
| IQLT | 48.85% | $11.95B | 0.3% |
| XLV | 48.32% | $34.14B | 0.09% |
| RSPH | 48.28% | $730.32M | 0.4% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -31.27% | $165.58M | 0.85% |
| TAIL | -28.49% | $99.49M | 0.59% |
| USDU | -19.71% | $163.19M | 0.5% |
| UUP | -19.11% | $209.45M | 0.77% |
| IVOL | -13.19% | $348.25M | 1.02% |
| TPMN | -13.00% | $30.70M | 0.65% |
| CTA | -12.33% | $1.06B | 0.76% |
| TBLL | -11.67% | $2.13B | 0.08% |
| CLIP | -11.49% | $1.51B | 0.07% |
| SHYM | -11.43% | $354.58M | 0.35% |
| BTAL | -10.48% | $295.67M | 1.43% |
| FTSD | -10.45% | $231.68M | 0.25% |
| CANE | -9.66% | $10.58M | 0.29% |
| XONE | -8.74% | $585.85M | 0.03% |
| UGA | -7.98% | $72.22M | 0.97% |
| STPZ | -7.59% | $450.05M | 0.2% |
| BILZ | -6.42% | $827.73M | 0.14% |
| CMBS | -5.89% | $448.71M | 0.25% |
| SHYD | -5.85% | $332.28M | 0.35% |
| USO | -5.83% | $1.22B | 0.6% |
Yahoo
Media ReleaseCOPENHAGEN, Denmark; July 1, 2025 Birgitte Stephensen, Executive Vice President and Chief Legal Officer to retire after 23 years with Genmab A/SGreg Mueller joins as new Executive Vice President, General Counsel and Chief Legal Officer, effective July 1 Genmab A/S (Nasdaq: GMAB) announced today that Birgitte Stephensen, Executive Vice President and Chief Legal Officer, will retire from Genmab after a successful tenure that spanned 23 years with the company. Greg Mueller joins Genmab
Yahoo
Company Announcement COPENHAGEN, Denmark; June 30, 2025 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on June 26, 2025. On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program was expected to be completed no later than July 10, 2025. The following transactions were executed under
Yahoo
Company Announcement COPENHAGEN, Denmark; June 23, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025. The following transactions were executed under the program from June 16 to June 20, 2025: Trading PlatformNo. of sharesAverag
SeekingAlpha
Discover why Genmab A/S stands out as a high-margin biotech with strong partnerships, robust growth prospects, and undervalued metrics. Click for more on GMAB.
Yahoo
Company Announcement COPENHAGEN, Denmark; June 17, 2025 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 32,117 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 27,396 shares at DKK 1,025.00,2,790 shares at DKK 1,050.00, 150 shares at DKK 1,147.50,1,557 shares at DKK 1,161.0
Yahoo
Company Announcement COPENHAGEN, Denmark; June 17, 2025 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading in Genm
Current Value
$20.351 Year Return
Current Value
$20.351 Year Return
